. Domestic Contract Manufacturing (CMG) sales grew by c.15% YoY, supported by new products launch, growth from some existing products as well as change of the sales platform of some CMG customer from export to
% Y o Y - 1 7 % Y o Y -10% YoY Page 3 Domestic Contract Manufacturing (CMG) sales increased by c.35% YoY, supported by new products launch, growth from some existing products as well as change of the
fruit juice sales following the slowdown in fruit juice market. Domestic CMG sales grew by c.5% YoY, supported by new products as well as growth from some existing products. Page 3 Export branded
Core EBITDA increased 40% YoY to $409 million, with gains across all segments and regions, driven by volume growth from new and existing assets and higher overall EBITDA per ton. Core EBITDA per ton of
same time, CPN plans to enhance the performances of GLAND’s existing assets to maximize the benefits and growth potential of GLAND going forward. International Expansion CPN envisions growth
enhance the performances of GLAND’s existing assets to maximize the benefits and growth potential of GLAND going forward. International Expansion CPN envisions growth opportunities beyond domestic sources
COMPANY LIMITED / THE KLINIQUE MEDICAL CLINIC PUBLIC COMPANY LIMITED Common share IPO GMO-Z COM SECURITIES (THAILAND) PUBLIC COMPANY LIMITED / By Existing Shareholders Common share IPO GMO-Z
approximately by 3.4% YoY. The resilient performance in 1H17 was due to the continuous growth of shopping mall business from new and renovated projects, and continual strong performance of existing projects such
and existing shopping malls, which contributed to a 3.8% growth in rental and services revenue. Food and beverages revenue increased by 16.6% courtesy of the incorporation of Food Destination zone (a
within 2019. At the same time, CPN plans to enhance the performances of GLAND’s existing assets to maximize the benefits and growth potential of GLAND going forward. International Expansion CPN envisions